Loading...

DocGo Inc.

DCGONASDAQ
Healthcare
Medical - Care Facilities
$0.68
$0.007(1.004%)
U.S. Market opens in 1h 34m

DocGo Inc. Fundamental Analysis

DocGo Inc. (DCGO) shows weak financial fundamentals with a PE ratio of -0.36, profit margin of -56.61%, and ROE of -71.45%. The company generates $0.3B in annual revenue with weak year-over-year growth of -1.24%.

Key Strengths

Cash Position76.15%
PEG Ratio-0.03
Current Ratio2.26

Areas of Concern

ROE-71.45%
Operating Margin-32.87%
We analyze DCGO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -86.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-86.8/100

We analyze DCGO's fundamental strength across five key dimensions:

Efficiency Score

Weak

DCGO struggles to generate sufficient returns from assets.

ROA > 10%
-84.02%

Valuation Score

Excellent

DCGO trades at attractive valuation levels.

PE < 25
-0.36
PEG Ratio < 2
-0.03

Growth Score

Weak

DCGO faces weak or negative growth trends.

Revenue Growth > 5%
-1.24%
EPS Growth > 10%
2.02%

Financial Health Score

Excellent

DCGO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.20
Current Ratio > 1
2.26

Profitability Score

Weak

DCGO struggles to sustain strong margins.

ROE > 15%
-7144.81%
Net Margin ≥ 15%
-56.61%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is DCGO Expensive or Cheap?

P/E Ratio

DCGO trades at -0.36 times earnings. This suggests potential undervaluation.

-0.36

PEG Ratio

When adjusting for growth, DCGO's PEG of -0.03 indicates potential undervaluation.

-0.03

Price to Book

The market values DocGo Inc. at 0.46 times its book value. This may indicate undervaluation.

0.46

EV/EBITDA

Enterprise value stands at -1.20 times EBITDA. This is generally considered low.

-1.20

How Well Does DCGO Make Money?

Net Profit Margin

For every $100 in sales, DocGo Inc. keeps $-56.61 as profit after all expenses.

-56.61%

Operating Margin

Core operations generate -32.87 in profit for every $100 in revenue, before interest and taxes.

-32.87%

ROE

Management delivers $-71.45 in profit for every $100 of shareholder equity.

-71.45%

ROA

DocGo Inc. generates $-84.02 in profit for every $100 in assets, demonstrating efficient asset deployment.

-84.02%

Following the Money - Real Cash Generation

Operating Cash Flow

DocGo Inc. produces operating cash flow of $34.73M, showing steady but balanced cash generation.

$34.73M

Free Cash Flow

DocGo Inc. produces free cash flow of $27.23M, offering steady but limited capital for shareholder returns and expansion.

$27.23M

FCF Per Share

Each share generates $0.28 in free cash annually.

$0.28

FCF Yield

DCGO converts 40.13% of its market value into free cash.

40.13%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.36

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.21

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.20

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.26

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.71

vs 25 benchmark

ROA

Return on assets percentage

-0.84

vs 25 benchmark

ROCE

Return on capital employed

-0.71

vs 25 benchmark

How DCGO Stacks Against Its Sector Peers

MetricDCGO ValueSector AveragePerformance
P/E Ratio-0.3629.88 Better (Cheaper)
ROE-71.45%682.00% Weak
Net Margin-56.61%-46037.00% (disorted) Weak
Debt/Equity0.200.42 Strong (Low Leverage)
Current Ratio2.264.49 Strong Liquidity
ROA-84.02%-16420.00% (disorted) Weak

DCGO outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews DocGo Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

1149.43%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

196.82%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

584.61%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ